Loading
Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
Site: Melanoma of skin. World: 331,722 new cases a year.
| # | Country | New cases | Incidence ASR |
|---|---|---|---|
| 1 | United States of America | 101,388 | |
| 2 | Germany | 21,976 | |
| 3 | United Kingdom | 19,712 | |
| 4 | Australia | 16,819 | |
| 5 | France (metropolitan) | 15,729 | |
| 6 | Italy | 13,769 | |
| 7 | Russian Federation | 12,903 | |
| 8 | Canada | 11,383 | |
| 9 | Brazil | 9,676 | |
| 10 | China | 8,789 |
Uveal and mucosal melanoma are not included.
Country-level death counts mix every stage, subtype and year of diagnosis, and reflect access to screening and treatment as much as the disease. Survival differs by stage, subtype and year; the cancer page above leads with what can be done.
| # | Country | New cases | Deaths |
|---|---|---|---|
| 1 | United States of America | 101,388 | 7,368 |
| 2 | Germany | 21,976 | 3,303 |
| 3 | United Kingdom | 19,712 | 2,626 |
| 4 | Australia | 16,819 | 1,393 |
| 5 | France (metropolitan) | 15,729 | 2,087 |
| 6 | Italy | 13,769 | 2,463 |
| 7 | Russian Federation | 12,903 | 3,928 |
| 8 | Canada | 11,383 | 1,369 |
| 9 | Brazil | 9,676 | 2,273 |
| 10 | China | 8,789 | 5,385 |
World: 331,722 new cases and 58,667 deaths a year (GLOBOCAN 2022).
Waiting-time standards, the specialist centres, what NICE and the SMC fund by line of treatment, the National Genomic Test Directory codes, the trials open in the UK and the differences across the four nations.
Baltimore · cancer center | United States | 0 | 2,962 | 42,161 | #10 | ||
Milan · cancer center | Italy | none recorded | 0 | 1,252 | 21,584 | #11 | |
| France | none recorded | 0 | 1,044 | 15,238 | #21 | ||
Barcelona · cancer center | Spain | none recorded | 0 | 967 | 23,548 | none recorded | #28 |
Stanford · university | United States | 0 | 3,016 | 50,896 | #30 | ||
Amsterdam · cancer center | Netherlands | none recorded | 1 | 1,457 | 26,241 | #45 | |
Naples · cancer center Programme: Melanoma immunotherapy trials | Italy | none recorded | 1 | 961 | 15,028 | - | |
Sydney · research institute Programme: Melanoma medical oncology, Melanoma pathology and biobanking | Australia | none recorded | 1 | 722 | 15,703 | none recorded | - |
Rosemont, IL · consortium Programme: SSO-ASTRO margins consensus and melanoma guidelines | United States | none recorded | 1 | 49 | 750 | - | |
Essen · cancer center Programme: Melanoma and dermato-oncology | Germany | none recorded | 1 | not matched | - | - | |
Bethesda, MD · government | United States | none recorded | 0 | 2,852 | 46,921 | - | |
Tampa, FL · cancer center | United States | 0 | 2,589 | 31,588 | - | ||
Los Angeles · cancer center Programme: Melanoma immunotherapy (Ribas) | United States | 0 | 2,039 | 33,523 | - | ||
Dallas, TX · cancer center | United States | 0 | 1,744 | 19,757 | - | ||
Miami, FL · cancer center | United States | 0 | 1,607 | 15,145 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Melanoma but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.
111 centres are named on one of the types below rather than on Melanoma itself. Grouped by the type that holds them; the full table for each sits on that type's page.